Bleeding Risk with Combination Antithrombotic Therapy

Introduction to Bleeding Risk

The combination of apixaban, clopidogrel, cilostazol, and hesperidin carries a significantly increased risk of bleeding, particularly gastrointestinal bleeding, with potential rates of major bleeding exceeding 5-15% at 1 year 1

Advanced age significantly increases the absolute risk of bleeding with antithrombotic agents 2
History of previous bleeding or peptic ulcer disease is the strongest risk factor for gastrointestinal bleeding in patients taking antiplatelet agents 2
Concurrent use of NSAIDs or steroids with this combination would further increase bleeding risk 2
Renal impairment increases bleeding risk with apixaban, requiring dose adjustments 3
Hepatic impairment also increases bleeding risk with apixaban 3

The American Heart Association suggests that this four-drug combination should generally be avoided due to the extremely high bleeding risk unless the thrombotic risk clearly outweighs bleeding concerns 1
If this combination is absolutely necessary, the American College of Cardiology recommends using the lowest effective dose of each agent 1
Consider proton pump inhibitor prophylaxis to reduce gastrointestinal bleeding risk, as recommended by the American Heart Association 4, 2
Limit the duration of triple or quadruple therapy to the shortest time possible, as suggested by the American College of Chest Physicians 1, 5

For patients with atrial fibrillation and coronary artery disease requiring PCI, the European Society of Cardiology suggests triple therapy with OAC, aspirin, and clopidogrel for only 3-6 months, then dual therapy with OAC and clopidogrel until 12 months 1, 6
For patients with peripheral artery disease requiring anticoagulation, consider dual therapy with apixaban and aspirin rather than triple therapy with clopidogrel, as recommended by the American Heart Association 7

Regular assessment for bleeding signs and monitor complete blood counts periodically, as recommended by the American College of Cardiology 1